# DALVANCE

NDC: 57970-100
Generic name: Dalbavancin
Labeler / Manufacturer: Allergan, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140523

FDA application: NDA021883

## Active ingredients

- DALBAVANCIN HYDROCHLORIDE: 500 mg/25mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57970-100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57970-100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4b4674d8-4d1e-4728-8465-d42ada33fa5c